Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva in advanced non-small cell lung cancer
NCT00091663Phase 3Completed
- Sponsor
- Genentech
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in non-small cell lung carcinoma (NSCLC), sponsored by Genentech. Started Aug 2004; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT00091663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091663.